Fuxiang Medical focuses on developing and producing silk fibroin materials and derivative medical biomaterials. The company provides innovative raw material products and technical services to universities, research institutes, and major biomedical enterprises. It draws on China’s silk culture to advance silk protein material development across multiple application areas. Fuxiang is working to overcome technical challenges in the scalable production and application development of degradable silk fibroin materials. The company supports clients in completing project research aimed at improving patient and clinical outcomes. Recently, Fuxiang completed an A round financing of nearly RMB 100 million.

Total raised

$14M

Funding rounds

1

Latest round

Series A

Latest activity

Aug 2024